Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies - a report from the Children's Cancer Group Study. - Rudnick,E.; Khakoo,Y.; Antunes,N.L.; Seeger,R.C.; Brodeur,G.M.; Shimada,H. (Med Pediatr Oncol, 2001)